Adage Capital Partners’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Adage Capital Partners’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-29,661	Closed	-$418K	–	959
2023 Q2	$418K	Buy	+29,661	New	+$424K	﹤0.01%	790
2021 Q4	–	Sell	-100,000	Closed	-$3.4M	–	1114
2021 Q3	$3.4M	Buy	+100,000	New	+$3.19M	0.01%	867
2021 Q1	–	Sell	-113,000	Closed	-$6.45M	–	1044
2020 Q4	$6.45M	Sell	113,000 -28,000	-20%	-$1.66M	0.01%	661
2020 Q3	$7.23M	Buy	+141,000	New	+$6.91M	0.02%	575
2017 Q4	–	Sell	-250,000	Closed	-$4.75M	–	762
2017 Q3	$4.75M	Buy	+250,000	New	+$4.58M	0.01%	628

Other funds holding DCPH

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Adage Capital Partners's DCPH Position: Q3 2023 in Review

Adage Capital Partners sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q3 2023, closing a stake of 29,661 shares — an estimated $418K sold.

Adage Capital Partners first reported a position in DCPH in Q3 2017 and held it in 5 quarters. The position peaked at $7.23M in Q3 2020. 157 funds tracked by Wall St. Rank hold DCPH as of Q3 2023.

Adage Capital Partners reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Adage Capital Partners sold 29,661 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q3 2023, an estimated $418K.
Adage Capital Partners first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q3 2017 and held it in 5 quarters.
Adage Capital Partners's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $7.23M in Q3 2020.
157 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q3 2023.

Based on Adage Capital Partners's 13F filing for Q3 2023, filed 14 Nov 2023.